Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 11/30/21
End: 11/30/22
Due: 11/30/23
Phase: N/A
Priority: Normal
Start: 02/27/20
End: 10/13/22
Due: 10/13/23
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| An Investigation of Oral BT051 in Subjects With Moderately to Severely Active Ulcerative Colitis (UC) | NCT05084261 | Adiso Therapeutics | user2@example.com | None | 2021-11-30 | 2022-11-30 | 2023-11-30 | - | - | 2025-07-14 |
| A Study of ART24 in Subjects Recently Cured of a Clostridioides Difficile Infection (CDI) | NCT04891965 | Adiso Therapeutics | user2@example.com | None | 2020-02-27 | 2022-10-13 | 2023-10-13 | - | - | 2025-07-14 |